Keywords:
Inflammatory biomarkers; Cardiovascular outcomes; Pharmacodynamic; Clinical trial endpoint validation
About:
Explore insights from ERG’s Chief Scientific Officer on clinical trials, obesity drug development, metabolic research, biomarkers, and emerging therapies.